(2) The stop-gain PTV in KMT2D, which encodes a histone methyltransferase that methylates the Lys-4 position of histone H3, is pathogenic for Kabuki syndrome (OMIM#147920), an autosomal dominant disorder characterised by intellectual disability and additional dysmorphic facial features. Here, KMT2D is linked to Kabuki syndrome.